Disease/Infection News

RSS

How nanomedicine is revolutionizing care for cardiovascular disease

Researchers review recent advancements in nanomedicine treatment options for cardiovascular disease.

6 Apr 2023

New machine learning model estimates optimal treatment timing for sepsis

A new machine learning model that estimates optimal treatment timing for sepsis could pave the way for support tools that help physicians personalize treatment decisions at the patient bedside, researchers say.

6 Apr 2023

Research opens the door to new approaches for tackling antibiotic-resistant TB

University of Otago researchers have discovered new ways to treat antibiotic-resistant strains of tuberculosis (TB), opening the door to new approaches for tackling the disease that kills about 4,000 people a day.

6 Apr 2023

Global antimicrobial resistance: socioeconomic factors play an underappreciated role in the spread

Researchers investigated the association between rates of antimicrobial resistance in animals and humans and environmental, socioeconomic, and anthropogenic indicators.

6 Apr 2023

Study reviews the diagnosis and treatment of acute myocarditis

Scientists have recently reviewed and summarized the evidence regarding diagnosing and treating acute myocarditis.

6 Apr 2023

The impact of perinatal low-calorie sweetener exposure on the development of neural systems involved in metabolic regulation

A study published in the Journal of Clinical Investigation Insight reveals that consumption of low-calorie sweeteners during pregnancy can affect the metabolism and neural development of the offspring.

6 Apr 2023

mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

Researchers assess the efficacy of monoclonal antibodies in treating COVID-19 caused by different viral variants.

6 Apr 2023

Parkinson's linked to higher levels of pheomelanin in brain: Could it be a biomarker or treatment target?

Researchers discover that the substantia nigra of individuals with Parkinson’s disease had a higher concentration of pheomelanin.

6 Apr 2023

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Researchers analyzed data on the association between intestinal microbiome dysbiosis and rheumatoid arthritis.

6 Apr 2023

Long COVID's significant impact on health calls for greater consideration in pandemic policy planning

Researchers estimated long coronavirus disease (COVID)-associated morbidity in the Australian population.

6 Apr 2023

Revolution in MDR-TB treatment: Shorter all-oral regimens

Researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy.

6 Apr 2023

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

Researchers assessed the safety and efficacy of fecal microbiota in preventing Clostridiodes difficile infection.

6 Apr 2023

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Researchers assessed the ability of spike proteins from 24 animal or human coronaviruses to utilize angiotensin-converting enzyme 2.

5 Apr 2023

Long COVID linked to increased sick leave rate

Researchers examined associations between coronavirus disease 2019 and sick leave post-acute infection.

5 Apr 2023

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

Researchers assessed the extent of SARS-CoV-2 Omicron VOC BA.5 sub-VOC infection-associated brain infection and death.

5 Apr 2023

The association between neutralizing antibody response breadth and long COVID symptoms

Researchers assessed neutralizing antibody responses before and after severe acute respiratory syndrome coronavirus 2 Omicron.

5 Apr 2023

Long-term protection and high efficacy of bivalent BA.1 booster confirmed in older adults

Researchers estimated the duration of protection with monovalent vaccination and the efficacy of bivalent vaccine boosters.

5 Apr 2023

Understanding how surface factors influence or inhibit biofilm formation in the presence of antibiotics

Similar to how cells within human tissues communicate and function together as a whole, bacteria are also able to communicate with each other through chemical signals, a behavior known as quorum signaling (QS).

5 Apr 2023

Key molecular pathway for organ damage in COVID patients discovered

Even after three years since the emergence of COVID-19, much remains unknown about how it causes severe disease, including the widespread organ damage beyond just the lungs.

5 Apr 2023

SFU researchers study pathogen genes to develop new drugs against bacterial infections

Researchers at Simon Fraser University are studying the genes of superbugs to aid the development of new and effective treatments for drug-resistant bacterial infections.

5 Apr 2023

Disease/Infection News

How nanomedicine is revolutionizing care for cardiovascular disease

New machine learning model estimates optimal treatment timing for sepsis

Research opens the door to new approaches for tackling antibiotic-resistant TB

Global antimicrobial resistance: socioeconomic factors play an underappreciated role in the spread

Study reviews the diagnosis and treatment of acute myocarditis

The impact of perinatal low-calorie sweetener exposure on the development of neural systems involved in metabolic regulation

mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

Parkinson's linked to higher levels of pheomelanin in brain: Could it be a biomarker or treatment target?

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Long COVID's significant impact on health calls for greater consideration in pandemic policy planning

Revolution in MDR-TB treatment: Shorter all-oral regimens

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

Study explores the species-specific use of ACE2 receptors by human and animal coronaviruses

Long COVID linked to increased sick leave rate

Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice

The association between neutralizing antibody response breadth and long COVID symptoms

Long-term protection and high efficacy of bivalent BA.1 booster confirmed in older adults

Understanding how surface factors influence or inhibit biofilm formation in the presence of antibiotics

Key molecular pathway for organ damage in COVID patients discovered

SFU researchers study pathogen genes to develop new drugs against bacterial infections

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News